Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Mckesson Medical-Surgical Inc. Corporate Office recalls Medroxyprogesterone Acetate Injectable Suspension

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Products
  • Medroxyprogesterone Acetate Injectable Suspension
Where it was sold

Distributed to Medical Facilities in MS and FL.

States: Florida, Mississippi

Units affected
3
About this recall
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01